Time to reperfusion: The critical modulator in thrombolysis and primary angioplasty

[1]  C. Lambrew.  The national heart attack alert program: A review , 2005, Journal of Thrombosis and Thrombolysis.

[2]  E. Antman,et al.  Time as an adjunctive agent to thrombolytic therapy , 2005, Journal of Thrombosis and Thrombolysis.

[3]  C. Cannon.  Time to treatment: A crucial factor in thrombolysis and primary angioplasty , 2004, Journal of Thrombosis and Thrombolysis.

[4]  P. Gordon.  Primary angioplasty for acute myocardial infarction. , 2001, Medicine and health, Rhode Island.

[5]  C. Cannon,et al.  Influence of door-to-balloon time on mortality in primary angioplasty results in 3,648 patients in the second national registry of myocardial infarction (NRMI-2) , 1996 .

[6]  S. Krall,et al.  Effect of continuous quality improvement methods on reducing triage to thrombolytic interval for acute myocardial infarction. , 1995, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[7]  H. Krumholz,et al.  Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. , 1995, JAMA.

[8]  C. Lambrew.  Emergency department triage of patients with nontraumatic chest pain , 1995 .

[9]  K. Lee,et al.  Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group. , 1995, The American journal of cardiology.

[10]  R. Califf,et al.  Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. , 1995, Circulation.

[11]  J Col,et al.  Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. , 1995, Circulation.

[12]  E. Antman,et al.  755-2 Current Management of ST Elevation Myocardial Infarction and Outcome of Thrombolytic Ineligible Patients: Results of the Multicenter TIMI 9 Registry , 1995 .

[13]  J. Kalbfleisch,et al.  715-5 Reteplase vs Alteplase Patency Investigation During Myocardial Infarction Trial (RAPID 2) , 1995 .

[14]  G. Reeder,et al.  956-115 Method of Reducing Emergency Room Time to Treatment for Acute Myocardial Infarction , 1995 .

[15]  M. Hand.  9-1-1 : rapid identification and treatment of acute myocardial infarction , 1995 .

[16]  J. Atkins,et al.  9-1-1: rapid identification and treatment of acute myocardial infarction. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee. , 1995, The American journal of emergency medicine.

[17]  C. Cannon,et al.  Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. , 1994, Journal of the American College of Cardiology.

[18]  H. Suryapranata,et al.  Limitation of Infarct Size and Preservation of Left Ventricular Function After Primary Coronary Angioplast Compared With Intravenous Streptokinase in Acute Myocardial Infarction , 1994, Circulation.

[19]  R. Califf,et al.  More on the GUSTO Trial , 1994, Annals of Internal Medicine.

[20]  W. Rogers,et al.  Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction. Alabama Registry of Myocardial Ischemia Investigators. , 1994, The American journal of cardiology.

[21]  J. Mcmanus.  Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT) , 1994 .

[22]  J. O’Keefe,et al.  Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry). , 1994, The American journal of cardiology.

[23]  C. Cannon,et al.  A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. , 1994, Journal of the American College of Cardiology.

[24]  E. Braunwald,et al.  GUSTO, TIMI and the case for rapid reperfusion. , 1994, Acta cardiologica.

[25]  J. Rawles.  Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). , 1994, Journal of the American College of Cardiology.

[26]  E. Braunwald.  The open-artery theory is alive and well--again. , 1993, The New England journal of medicine.

[27]  Gusto Angiographic Investigators.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[28]  B. Gersh,et al.  Thrombolysis and Myocardial Salvage Results of Clinical Trials and the Animal Paradigm‐ Paradoxic or Predictable? , 1993, Circulation.

[29]  L. Becker,et al.  TIMI Perfusion Grade 3 but Not Grade 2 Results in Improved Outcome After Thrombolysis for Myocardial Infarction Ventriculographic, Enzymatic, Electrocardiographic Evidence From the TEAM‐3 Study , 1993, Circulation.

[30]  J. Reiber,et al.  A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. , 1993, The New England journal of medicine.

[31]  J O'Keefe,et al.  A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .

[32]  K. Bailey,et al.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.

[33]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[34]  U. Tebbe,et al.  Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS) , 1992, Journal of the American College of Cardiology.

[35]  David Hunt,et al.  ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION , 1992 .

[36]  R. Luepker,et al.  Consequences of a media campaign focusing on delay in acute myocardial infarction. , 1992, American Journal of Cardiology.

[37]  K. Fox,et al.  Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis. , 1992, BMJ.

[38]  J. Anderson,et al.  Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction. , 1992, Journal of the American College of Cardiology.

[39]  F. Sheehan,et al.  Does arterial patency 90 minutes following thrombolytic therapy predict 42 day survival , 1991 .

[40]  E. Braunwald,et al.  Optimizing thrombolytic therapy of acute myocardial infarction. , 1990, Circulation.

[41]  J. Anderson,et al.  Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. , 1990, The American journal of cardiology.

[42]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction , 1990, The Lancet.

[43]  T. A. S. Group.  In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin , 1990, The Lancet.

[44]  P. Kudenchuk,et al.  Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. , 1990, Journal of the American College of Cardiology.

[45]  E. Ruiz,et al.  An analysis of time delays preceding thrombolysis for acute myocardial infarction. , 1989, JAMA.

[46]  J. O’Keefe,et al.  Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. , 1989, The American journal of cardiology.

[47]  I. Belenkie,et al.  Importance of effective, early and sustained reperfusion during acute myocardial infarction. , 1989, The American journal of cardiology.

[48]  E. Braunwald,et al.  Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? , 1989, Circulation.

[49]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[50]  E. Braunwald,et al.  Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. , 1988, The American journal of cardiology.

[51]  J. Clem.  Thrombolytic Therapy for Acute Myocardial Infarction , 1987, The Lancet.

[52]  J. Ritchie,et al.  Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial. , 1986, Circulation.

[53]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[54]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[55]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[56]  W. Ganz.  Intracoronary thrombolysis in evolving myocardial infarction. , 1981, Annals of internal medicine.

[57]  K. Karsch,et al.  Initial experience with transluminal recanalization of the recently occluded infarct‐related coronary artery in acute myocardial infarction — Comparison with conventionally treated patients , 1979, Clinical cardiology.

[58]  J. Lowe,et al.  The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.